Dermata Therapeutics, Inc. (DRMA) News
Track canonical SquawkNews coverage tagged to DRMA, Dermata Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Dermata Therapeutics announces $3.4M at-the-market private placement
Dermata Therapeutics (DRMA) announces a $3.4 million private placement priced at-the-market under Nasdaq rules, with details not provided in the feed.
REGULATION | Aug 17, 2026, 12:30 PM UTC
H
Premarket Top Gainers: BAOS Leads
BAOS gains 175.66% in premarket trading, leading the top ten gainers
EQUITY | Aug 12, 2026, 09:30 AM UTC
L
DRMA Leads Health Care Gainers
Dermata Therapeutics stock rises 44.4% to $1.56 after Q2 earnings report
EARNINGS | Aug 11, 2026, 09:06 PM UTC
L
Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate
Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate
EARNINGS | Aug 11, 2026, 08:37 PM UTC
H
Dermata Launches Tome Foundational Treatment
Dermata launches Tome treatment commercially
EQUITY | Aug 05, 2026, 12:30 PM UTC